Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.015(1.37%) |
Mkt cap ! $2.988B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.11 | $1.09 | $6.539M | 5.903M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 215332 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 100334 | 12 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.11 |
Change
0.015 ( 0.69 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.11 | $1.10 | 768417 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| AMP (ASX) Chart |
